Histórico, tendências e perspectivas no planejamento espacial de usinas hidrelétricas brasileiras: a antiga e atual fronteira Amazônica

Os empreendimentos hidrelétricos são alternativas favoráveis economicamente em função do grande potencial hidrelétrico disponível no território brasileiro. Apesar de serem notórias em causar significativa degradação ambiental, conformam historicamente uma importante controvérsia do setor energético brasileiro. Orientado por esta problemática, o presente trabalho tem como objetivo principal analisar o histórico e as tendências do planejamento espacial de usinas hidrelétricas no Brasil, interpretando-os a partir da relação entre o potencial hidrelétrico disponível no espaço e o grau de disciplinamento do uso e ocupação do espaço no tempo. Até a década de 1970, a implantação de hidrelétricas ocorreu, relativamente, à luz de menor grau de disciplinamento de uso e ocupação do espaço, como foi o caso das hidrelétricas de Balbina e Tucuruí, as quais também induziram a primeira grande crise ambiental do setor e favoreceram a criação dos instrumentos de política ambiental, em 1981. As décadas de 1980 e 1990 são caracterizadas por um vazio de planejamento de hidrelétricas, o que é retomado a partir de 2000 em função de um ambiente econômico internacional favorável aos investimentos em infraestrutura, resultando no aumento da exploração do potencial hidrelétrico orientada especialmente para a região Amazônica. Porém, esta reorientação depara-se com um maior grau de disciplinamento do uso do espaço que acaba vinculando novas dimensões para o planejamento espacial de hidrelétricas, especialmente em regiões com alta sensibilidade socioambiental, como é o caso da Amazônica. Ainda assim, esta região é aquela que ainda detêm o maior potencial hidrelétrico a ser explorado, o que faz dela a escolhida como a fronteira hidrelétrica da década de 2010.

The Brazilian National Health Agency and the Mental Health Policy in the Context of the Private Health System: developments and challenges

This work analyses the mental health policy-making activity of the Brazilian National Health Agency (ANS), responsible for controlling health insurance companies. Three points are discussed: a) the framework of an economic and private health assistance regulatory activity, b) the ANS and its regulation activity and c) the rules produced by ANS in the mental health care field. It was concluded that, despite advances like the legal obligation to ensure medical treatment to all the diseases listed in ICD-10, the inclusion of suicidal patient damage and self-inflicted damage care, care provided by a multiprofessional team, the increase in the number of sessions with a psychologist, with an occupational therapist and of psychotherapy sessions, and mental health day hospitals included as part of the services offered, the authors identified specific regulatory gaps in this area. Some issues that ANS has to solve so that it can really play its institutional role of defending the public interest in the private health system are: the regulation of co-participation and franchise mechanisms, the increasing co-participation as a limitation of psychiatric hospitalization, and the limited number of crisis intervention psychotherapy sessions.

Cost-effectiveness analysis of universal childhood hepatitis A vaccination in Brazil: Regional analyses according to the endemic context

Objective: To To conduct a cost-effectiveness analysis of a universal childhood hepatitis A vaccination program in Brazil. Methods: An age and time-dependent dynamic model was developed to estimate the incidence of hepatitis A for 24 years. The analysis was run separately according to the pattern of regional endemicity, one for South + Southeast (low endemicity) and one for the North + Northeast + Midwest (intermediate endemicity). The decision analysis model compared universal childhood vaccination with current program of vaccinating high risk individuals. Epidemiologic and cost estimates were based on data from a nationwide seroprevalence survey of viral hepatitis, primary data collection, National Health Information Systems and literature. The analysis was conducted from both the health system and societal perspectives. Costs are expressed in 2008 Brazilian currency (Real). Results: A universal immunization program would have a significant impact on disease epidemiology in all regions, resulting in 64% reduction in the number of cases of icteric hepatitis, 59% reduction in deaths for the disease and a 62% decrease of life years lost, in a national perspective. With a vaccine price of R$16.89 (US$7.23) per dose, vaccination against hepatitis A was a cost-saving strategy in the low and intermediate endemicity regions and in Brazil as a whole from both health system and society perspective. Results were most sensitive to the frequency of icteric hepatitis, ambulatory care and vaccine costs. Conclusions: Universal childhood vaccination program against hepatitis A could be a cost-saving strategy in all regions of Brazil. These results are useful for the Brazilian government for vaccine related decisions and for monitoring population impact if the vaccine is included in the National Immunization Program. (C) 2012 Elsevier Ltd. All rights reserved.

Contributions from the systematic review of economic evaluations: the case of childhood hepatitis A vaccination in Brazil

The aim of this study was to present the contributions of the systematic review of economic evaluations to the development of a national study on childhood hepatitis A vaccination. A literature review was performed in EMBASE, MEDLINE, WOPEC, HealthSTAR, SciELO and LILACS from 1995 to 2010. Most of the studies (8 of 10) showed favorable cost-effectiveness results. Sensitivity analysis indicated that the most important parameters for the results were cost of the vaccine, hepatitis A incidence, and medical costs of the disease. Variability was observed in methodological characteristics and estimates of key variables among the 10 studies reviewed. It is not possible to generalize results or transfer epidemiological estimates of resource utilization and costs associated with hepatitis A to the local context. Systematic review of economic evaluation studies of hepatitis A vaccine demonstrated the need for a national analysis and provided input for the development of a new decision-making model for Brazil.